EMD-22995

Single-particle
2.51 Å
EMD-22995
3D View Gallery
Deposition: 14/11/2020
Map released: 22/09/2021
Last modified: 22/09/2021
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-22995

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Spike protein trimer

EMD-22995

Single-particle
2.51 Å
EMD-22995
3D View Gallery
Deposition: 14/11/2020
Map released: 22/09/2021
Last modified: 22/09/2021
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 Spike protein trimer

Deposition Authors: Asarnow D, Faust B, Bohn M, Bulkley D, Manglik A, Craik CS, Cheng Y
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.
Asarnow D, Wang B, Lee WH, Hu Y, Huang CW, Faust B, Ng PML, Ngoh EZX, Bohn M, Bulkley D, Pizzorno A, Ary B, Tan HC, Lee CY, Minhat RA, Terrier O, Soh MK, Teo FJ, Yeap YYC, Seah SGK, Chan CEZ, Connelly E, Young NJ, Maurer-Stroh S, Renia L, Hanson BJ, Rosa-Calatrava M, Manglik A, Cheng Y, Craik CS, Wang CI
(2021) Cell , 184 , 3192 - 3204.e16
DOI: doi:10.1016/j.cell.2021.04.033
ISSN: 1097-4172